Damps T et al. |
The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment. |
2017 |
PLoS ONE |
pmid:28859143
|
Asche CV et al. |
Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States. |
2016 Mar-Apr |
Value Health |
pmid:27021759
|
Zane C et al. |
A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp. |
2016 |
Dermatology (Basel) |
pmid:27578305
|
Erlendsson AM et al. |
Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice. |
2016 |
PLoS ONE |
pmid:27636884
|
Emmert S et al. |
Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate. |
2016 |
PLoS ONE |
pmid:27612149
|
Liu M et al. |
Synthesis and Cytotoxicity against K562 Cells of 3-O-Angeloyl-20-O-acetyl Ingenol, a Derivative of Ingenol Mebutate. |
2016 |
Int J Mol Sci |
pmid:27548156
|
Mohanna MT and Hofbauer GF |
Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate. |
2016 |
Dermatology (Basel) |
pmid:27513957
|
Mainetti C et al. |
Successful Treatment of Relapsing Bowen's Disease with Ingenol Mebutate: The Use of Dermoscopy to Monitor the Therapeutic Response. |
2016 |
Dermatology (Basel) |
pmid:27513936
|
Gaide O et al. |
Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization. |
2016 |
Dermatology (Basel) |
pmid:27513862
|
Gaide O and Cattin V |
Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis. |
2016 |
Dermatology (Basel) |
pmid:27513756
|